Traws Pharma, Inc. (TRAW) Revenue 2015–2024
Traws Pharma, Inc. (TRAW) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$2.8MFY2024 · since FY2015: $5.5M → $2.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $2.8M | +1134.5% |
| FY2023 | $226,000 | +0.0% |
| FY2022 | $226,000 | +0.0% |
| FY2021 | $226,000 | +0.0% |
| FY2020 | $226,000 | -2.2% |
| FY2019 | $231,000 | -89.4% |
| FY2018 | $2.2M | +77.8% |
| FY2017 | $1.2M | +56.0% |
| FY2016 | $787,000 | -85.8% |
| FY2015 | $5.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TRAW financial trends
TRAW Net incomeTRAW Net marginTRAW Gross profitTRAW Gross marginTRAW Operating incomeTRAW Operating marginTRAW Operating cash flowTRAW Free cash flowTRAW Capital expendituresTRAW Return on equityTRAW Stock buybacksTRAW Dividends paidTRAW Total assetsTRAW Total liabilitiesTRAW Shareholders’ equityTRAW overview →